Safinamide: New Drug Tested on Parkinson's Disease Patients

Safinamide (Xadago), the new, first approved drug by the FDA to treat Parkinson's disease has just been approved for clinical use in the United States. This is the first known drug to treat Parkinson's in more than 10 years. It is a form of add-on treatment that is used in conjunction with levodopa.

 

Click below the link to view the contents:

 

http://www.ba-bamail.com/content.aspx?emailid=25424